Anti-beta 2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome

Inanc M., Donohoe S., Ravirajan C., Radway-Bright E., Mackie I., Machin S., ...Daha Fazla

BRITISH JOURNAL OF RHEUMATOLOGY, cilt.37, sa.10, ss.1089-1094, 1998 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 10
  • Basım Tarihi: 1998
  • Dergi Adı: BRITISH JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.1089-1094
  • Anahtar Kelimeler: systemic lupus erythematosus, antiphospholipid syndrome, anti-beta 2 glycoprotein-I, anti-prothrombin, CLINICAL MANIFESTATIONS, GLYCOPROTEIN-I, BETA-2-GLYCOPROTEIN-I, ELISA, BETA(2)-GLYCOPROTEIN-I, AUTOANTIBODIES, SPECIFICITY, ASSAY
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective. To determine anti-beta 2 glycoprotein-I (anti-beta 2GPI) and anti-prothrombin (anti-ProT) antibody levels, and the IgG subclass distribution of anti-beta 2GPI antibodies, in serial samples from patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) having initial or recurrent thrombotic/neurological (T/N) events during the study period. To investigate the correlations between these antibodies and beta 2GPI antigen, anticardiolipin antibody (aCL), anti-double-stranded (ds) DNA, C3 levels and disease activity.